Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
06 May 2026 |
On P&L |
The Company releases the press release related to the first three months of 2026 financial results.
|
Download |
|
06 May 2026 |
On P&L |
The Company releases the first three months of 2026 financial results presentation.
|
Download |
|
25 Feb 2026 |
On P&L |
The Company releases the press release related to the full year 2025 financial results.
|
Download |
|
25 Feb 2026 |
On P&L |
The Company releases the full year 2025 financial results presentation.
|
Download |
|
25 Feb 2026 |
About Corporate Governance |
The Company informs about the agreements adopted by the Board of Directors.
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
22 Mar 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 15 March and 21 March 2024
|
Download |
|
15 Mar 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 8 March and 14 March 2024
|
Download |
|
12 Mar 2024 |
On business and financial situation |
ROVI, Insud Pharma and Innvierte (CDTI) create a company for the research and development of advanced therapies
|
Download |
|
08 Mar 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 1 March and 7 March 2024
|
Download |
|
07 Mar 2024 |
On corporate transactions |
ROVI notes the recent press speculation and informs about the assessment of potential strategic alternatives
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
26 Feb 2019 |
Información sobre resultados |
ROVI releases the presentation related to the full year 2018 results
|
Download |
|
26 Feb 2019 |
Información sobre resultados |
ROVI releases the press release related to the full year 2018 results
|
Download |
|
15 Feb 2019 |
Others on business performance and financial information |
ROVI acquires rights to Dexchlorpheniramine Maleate in the Spanish and French markets
|
Download |
|
09 Jan 2019 |
Others on business performance and financial information |
ROVI informs about the adquisition of Falithrom® for the German market
|
Download |
|
08 Jan 2019 |
Liquidity contracts and specialists |
Liquidity contract: transactions conducted in the fourth quarter of 2018
|
Download |
Pages
